digital therapeutics
Industry regulatory leaders outline the best approaches for digital health companies looking to make sense of FDA's long-in-the-tooth enforcement discretion guidelines.
Panelists from DTx West share how they successfully executed a digital therapeutic and payer relationship.
The randomized controlled trial of the jointly-developed digital therapeutics will be conducted using Verily's Project Baseline and enroll up to 540 patients.
MobiHealthNews spoke with Pear Therapeutics, Click Therapeutics and DTx newcomer Mahana Therapeutics to discuss whether in-licensing is the way to go for those just entering the space.
The results will not impact the current rollout of a new version of the app, under special FDA guidelines.
Mahana Therapeutics' Parallel is a three-month digital treatment that logs patients' symptoms to deliver relevant guidance and teach them condition-management skills.
The company currently has three prescription digital therapeutics available on the market.
The solution aims to support pulmonary rehabilitation through behavioural change rather than relying on pharmacology.
Authors from GIMBHI and Columbia Psychiatry Mind Ventures write about the future of digital therapeutics.
The cognitive behavioral therapy for insomnia program is designed to be an end-to-end virtual experience.